Lincoln Pharma Share Price
NSE: LINCOLN|BSE: 531633|Pharmaceuticals₹558.70
+₹8.70 (1.58%) As on 05 Sep, 2025 | 15:50 ISTLincoln Pharma Stock Performance
Market cap  ₹1,102 Crs | Open ₹553.95 | Prev. Close ₹550.00 |
Circuit range ₹660.00 - ₹440.00 | Day range ₹545.10 - ₹563.00 | Year range ₹499.00 - ₹979.50 |
Volume 33,647 | Avg. traded ₹556.46 | Revenue (12m) ₹630 Crs |
About Lincoln Pharma
Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading of pharmaceutical products like medicines, injections and other related products. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, anti-diabetic, and anti-malaria. The Company serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms), and Tinnex Capsule used to treat tinnitus.
As of last trading day, Lincoln Pharma opened at ₹553.95 and last traded at ₹558.70, showing a rise of 8.70 points (1.58%) compared to the previous close of ₹550.00. During the session, the stock touched a high of ₹563.00 and a low of ₹545.10. The company's market capitalization now stands at ₹1,102 Crs, with a P/E ratio of 12.8 and a dividend yield of 0.31%.
06 September 2025 – Lincoln Pharma Share Price Update
As of last trading day, Lincoln Pharma opened at ₹553.95 and last traded at ₹558.70, showing a rise of 8.70 points (1.58%) compared to the previous close of ₹550.00. During the session, the stock touched a high of ₹563.00 and a low of ₹545.10. The company's market capitalization now stands at ₹1,102 Crs, with a P/E ratio of 12.8 and a dividend yield of 0.31%.Lincoln Pharma Share Price Chart
₹558.70+₹8.70 (1.58%)
Please wait...
Lincoln Pharma Key Indicators
P/E ratio 12.76 | P/B ratio 1.98 | ROE -- |
ROCE -- | Dividend yield 0.31% | Debt/Equity ratio 0 |
EPS 41.11 |
Lincoln Pharma Financial Ratios
Operating profit margin0% | Net profit margin0% |
ROE0% | ROA0% |
ROCE0% |
Quick ratio0 | Current ratio0 |
Interest coverage0 | Asset turnover0.9 |
Debt to Equity0 |
P/E ratio12.76 | P/B ratio1.98 |
EV / EBITDA0 | |
Dividend yield0.31% |
Lincoln Pharma Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-25 | ₹645.71 | ₹109.19 | ₹82.35 |
Mar-24 | ₹614.97 | ₹122.24 | ₹93.30 |
Mar-23 | ₹532.78 | ₹100.48 | ₹72.90 |
Mar-22 | ₹482.12 | ₹95.94 | ₹69.36 |
Lincoln Pharma Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-24 | ₹-57.34 | ₹-5.18 | |
Mar-23 | ₹-36.64 | ₹-4.50 | |
Mar-22 | ₹-78.08 | ₹-2.56 | |
Mar-21 | ₹-64.23 | ₹-5.75 |
Lincoln Pharma Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-24 | ₹700.29 | ₹700.29 |
Mar-23 | ₹587.42 | ₹587.42 |
Mar-22 | ₹534.36 | ₹534.36 |
Mar-21 | ₹452.36 | ₹452.36 |
Lincoln Pharma Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
21-Aug-25 | ₹558.70 | ₹548.25 | -1.62% |
20-Aug-25 | ₹555.35 | ₹557.25 | -0.66% |
19-Aug-25 | ₹546.35 | ₹560.95 | |
18-Aug-25 | ₹543.30 | ₹546.35 | |
14-Aug-25 | ₹545.00 | ₹542.65 | -0.33% |
13-Aug-25 | ₹553.00 | ₹544.45 | -0.41% |
12-Aug-25 | ₹553.00 | ₹546.70 | |
11-Aug-25 | ₹558.95 | ₹546.05 | -2.90% |
Lincoln Pharma Corporate Actions
Dividend • ₹1.8/share
Ex date 13 Sep 2024
Dividend • ₹1.5/share
Ex date 15 Sep 2023
Stocks Similar to Lincoln Pharma
Stock Name | Price | Change % |
|---|---|---|
| ANUH PHARMA LIMITED | ₹84.57 | -₹0.85 (-1%) |
| BETA DRUGS LIMITED | ₹1,900.00 | +₹15.30 (0.81%) |
| FERMENTA BIOTECH LIMITED | ₹339.00 | +₹5.80 (1.74%) |
| Lyka Labs | ₹99.25 | -₹0.38 (-0.38%) |
| Nectar Lifesciences | ₹14.70 | +₹0.04 (0.27%) |
| Syncom Formulations | ₹17.21 | +₹0.06 (0.35%) |
| Windlas Biotech | ₹993.60 | +₹9.75 (0.99%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| HDFC Bank Share Price | ₹963.40 | +₹2.15 (0.22%) |
| IDFC First Bank Share Price | ₹72.60 | +₹0.37 (0.51%) |
| Indian Railway Finance Corp Share Price | ₹123.46 | +₹1.83 (1.50%) |
| ITC Share Price | ₹407.35 | -₹8.55 (-2.06%) |
| JIO FIN SERVICES LTD Share Price | ₹309.40 | -₹0.05 (-0.02%) |
| NTPC Share Price | ₹328.70 | -₹1.35 (-0.41%) |
| Reliance Share Price | ₹1,375.00 | +₹15.70 (1.16%) |
| Tata Motors Share Price | ₹691.70 | +₹4.20 (0.61%) |
| Tata Power Share Price | ₹385.80 | +₹3.20 (0.84%) |
| Tata Steel Share Price | ₹167.68 | +₹0.87 (0.52%) |
Lincoln Pharma Share Price FAQs
What is the share price of Lincoln Pharma today?
Lincoln Pharma share price is ₹ 558.70 as on Sep, 2025 | 15:50 IST.
What are the high & low stock price of Lincoln Pharma today?
Lincoln Pharma stock price hit a high of ₹ 563.00 and low of ₹ 545.10 as on Sep, 2025 | 15:50 IST.
What is the market cap of Lincoln Pharma?
The market cap of Lincoln Pharma is ₹ 1,101.63 Crores as on Sep, 2025 | 15:50 IST.
What are the the 52-week high and low share prices of Lincoln Pharma stock on the NSE?
52-week high stock Price of Lincoln Pharma is ₹ 979.50 and Low Price is ₹ 499.00 as on Sep, 2025 | 15:50 IST.
What are the stock symbols of Lincoln Pharma?
The stock symbol of Lincoln Pharma is NSE: LINCOLN on the NSE, BSE: 531633 on the BSE, and the ISIN is INE405C01035.
Can I buy Lincoln Pharma shares on Holidays?
No, shares of Lincoln Pharma or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Lincoln Pharma shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
How to buy Lincoln Pharma shares?
To buy Lincoln Pharma shares,open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order
What is the PE and PB ratio of Lincoln Pharma?
The PE and PB ratio of Lincoln Pharma is 12.76 and 1.98 respectively, as on Sep, 2025 | 15:50 IST.
What are the returns on Lincoln Pharma shares?
The historical returns for Lincoln Pharma shares are -22.96 for 1 year, 90.31 for 3 year and 130.85 for 5 year.